From the Clinic to Biotech: How Vertex Hopes to Transform the Treatment Landscape for Type 1 Diabetes

By Tina Gupta, MD

December 13, 2023

Endocrine Society member Tina Gupta, MD, always possessed a passion for helping her patients with type 1 diabetes overcome their daily struggles. She gives Endocrine News an exclusive account of why she made the move to the biotech industry by joining Vertex Pharmaceuticals, thus ensuring that her enthusiasm for patient-centered care can now help as […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today

RELATED ARTICLES

Heroin Adulterated with Diabetes Medication Triggers Life-Threatening Medical Emergencies

Hyperinsulinemia Emerges as Critical Predictor of Severe Liver Outcomes

Father’s Tobacco Use May Raise Children’s Diabetes Risk

Health Topics

Patient Populations